Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Qasim Ahmad
20 years of experience in strategic global medical affairs & clinical development leadership across multiple therapy areas leading cross-functional teams in all major geographies.
Trained as Oncologist/ Internal Medicine/ Pharmaceutical Physician/ Health Policy Management.
Expertise in medical affairs strategy, medical excellence & capability building, launch excellence, successful hands-on national and international experience leading large organizations and teams running drug development clinical research. Expert in bridging development data gaps, generating and disseminating data, innovative medical education programs and translating scientific insights into strategies.
Substantial command improving & creating processes for handling medical compliance; regulations and managing off-label drug use access programs. Track record building capability and efficiency using innovative new tool for HEOR/ Real World Evidence data generation.
Thorough understanding and in-depth knowledge of changing health system dynamic, regulatory and pharmaco-economic challenges including HTA assessments (i.e NICE) and role of pharmaceutical industry as well as non-governmental/private health care providers. Experience in leading corporate responsibility efforts working with health system supporting sustainable health delivery programs
Experience leading drug development and registration with USA (FDA), EU (EMEA), Japan (PMDA), China (CFDA) & other EU/ROW authorities. Champion Ethical Practices with command on IFPMA/EFPIA,ABPI/PhRMA.
Passionate about people development and growth, incorporating on job and role based trainings to build capabilities and develop next generation leadership.
Richa Attre
Richa Attre, PhD, MBA is Associate Director, publications, Medical Affairs for Regeneron Pharmaceuticals, Inc. Richa has over 20 years of experience in pharmaceutical, biotechnology and medical communications agencies in several therapy areas, including autoimmune diseases, cardiovascular, dermatology, genomics, hematology, immunology, infectious disease, inflammation, metabolic diseases, musculoskeletal, pain, respiratory diseases, surgery, and vaccines.
Previously Richa was an adjunct faculty at UConn and worked as senior scientist in clinical R&D where she helped develop genomic detection diagnostic kits.
Richa earned a MPhil in biochemistry and PhD. in Molecular Cell Biology both from University of Cambridge, UK; post-doctoral fellow in microbiology and immunology at Stanford Medical School; MBA at UConn and is completing an MPH at Yale.
Marc Rubinstein
Dr. Marc Rubinstein joined Werfen (Instrumentation Laboratory) in 2016 as the new Medical Director. His current role is building the relatively new medical affairs team, leading the medical affairs strategy, as well the medical science liaison team.
Prior to joining Werfen, Marc served as the Sr. Manager Global Medical Affairs at Baxter Healthcare. He specialized in KOL’s and fostering publications related to medical device products.
Prior to joining the industry, Marc spent several years in academia at the University of California, Irvine working with various medical devices and medical imaging technology where he published several peer-review journals as well as multiple book chapters.
Marc holds a Medical Doctor degree from the Universidad Anahuac, Mexico. He did his general surgery residency at the University of Southern California and Huntington Hospital in Los Angeles, California. He is currently doing his MBA at the Haslam College of Business (U Tennessee Knoxville).
Renu Juneja
Renu Juneja is Head of Scientific Evidence and Communications at Janssen Biotechnology Inc (JBI). Her team has the responsibility for publication plans, medical education, medical booth content, KOL engagements, MSL slide decks & training, cooperative studies and clinical trial operations in Oncology Medical affairs at JBI. Before joining Janssen, Renu was head of the Medical Communications group at MedImmune (the worldwide biologics research and development arm of AstraZeneca). Her group had the responsibility for both regulatory documents and development & execution of strategic publication plans. Her team supported all therapeutic areas including Immuno-oncology, respiratory, inflammation, CVMD, infectious diseases and vaccines.
Previously, she led the Strategic Scientific Communication (SSC) group at Novo Nordisk Inc. (NNI). She also had the opportunity to lead the Information & Education group at NNI and was responsible for the company’s library and for Independent Medical Education (IMEs) programs. Renu started her career in Novo Nordisk as a medical writer. After finishing her PhD in Reproductive Biology & Biochemistry from the Post-Graduate Institute of Medical Education & Research (PGIMER) in India, Renu joined The Population Council in NY as a Postdoctoral fellow. Two years later, she received an independent research grant from the Lalor Foundation and joined the department of Molecular Biology at the Princeton University. She has over 30 publications in peer-reviewed journals and has presented at various national and international conferences.
Renu has presented and conducted workshops at the annual meetings of various professional organizations e.g. ISMPP, TIPPA, CBI, and Q1 productions.